Beta-lactam and Beta-lactamase Inhibitors Market Size Worth USD 34.17 Million by 2028 at a CAGR of 2.3%

The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028.

The beta-lactam and beta-lactamase inhibitors market is projected to grow due to increased consumption in LMICs and rising infectious disease prevalence. However, antibiotic resistance and regulatory approval delays may hinder growth. Nonetheless, discovery of new molecules and combination therapies present profitable opportunities for market players.

Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427

Key Findings of the Beta-lactam and Beta-lactamase Inhibitor Market:

• Based on drug class, cephalosporin segment was the major revenue contributor in 2018 and is anticipated to continue this trend during the forecast period.
• Based on disease segment, its complicated intra-abdominal infection (cIAI) is expected to exhibit the highest CAGR with 4.8% during the forecast period.
• Depending on route of administration, the oral segment was the largest revenue contributor in 2018 and expected to continue this trend from 2019 to 2028.
• U.S. generated the highest revenue in the global beta-lactam and beta-lactamase inhibitors in 2018, accounting more than one-fifth of the global market in 2018.
LAMEA is estimated to grow at a highest CAGR during the forecast period.

Beta-lactam and Beta-lactamase Inhibitors Market Players

• Merck & Co. Inc.
• Abbott Laboratories
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Sanofi
• Mylan N.V.
• F. Hoffmann-La Roche Ltd.
• Novartis International AG (Sandoz)
• Allergan Plc.
• GlaxoSmithKline plc

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/5427

Asia-Pacific emerged as the primary revenue generator for the global market of beta-lactam and beta-lactamase inhibitors in 2018, and this dominance is projected to continue in the foreseeable future. The region's leading position can be attributed to several factors, including a significant increase in chronic diseases, a growing elderly population, a rise in the consumption of antibiotics, and the easy availability of drugs without prescription.

Key Benefits for Beta-lactam and Beta-lactamase Inhibitors Market:

• This report provides a detailed quantitative analysis of the current beta-lactam and beta-lactamase inhibitors market trends and estimations from 2018 to 2028, which assists to identify the prevailing opportunities.
• An in-depth market analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of the factors that drive and restrain the beta-lactam and beta-lactamase inhibitors market growth of the market is provided.
• Region-wise and country-wise market conditions are comprehensively analyzed in this report.
• The projections in this report are made by analyzing the current trends and future market potential from 2019 to 2028 in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps to understand the competitive outlook of the global market.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
• Which region has more opportunities?

By Region Outlook

North America
(U.S., Canada, Mexico)
Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.